Is naltrexone suitable?
Current opioid use, recent opioid exposure, pregnancy, liver history, other medicines, and mental health can change the risk-benefit decision.
Targeted naltrexone for alcohol use
What is the Sinclair Method?
The Sinclair Method is a popular name for taking prescribed naltrexone in relation to anticipated drinking instead of automatically taking it every day. It is an approach to dosing—not a separate medicine or guaranteed cure.
The part online success claims often leave out
Targeted naltrexone has randomized-trial evidence for some alcohol outcomes in selected groups. It also asks a person to anticipate drinking and follow a timing plan, which may not fit unplanned drinking or everyone’s treatment goal.
The trials do not show that 78% of everyone treated succeeds or that most people reach ‘extinction’ on a fixed schedule. Daily naltrexone also has a substantial evidence base and is the labelled or guideline-supported approach in many settings. The useful question is which plan fits the person, the evidence, and the local label.
What the principal targeted-dosing trials show
| Study | Design | What it found | Important limit |
|---|---|---|---|
| Heinälä et al., 2001 | 121 people; naltrexone or placebo with coping-skills or supportive therapy | During 12 weeks of daily treatment, naltrexone plus coping skills reduced relapse to heavy drinking; a 20-week targeted phase followed | The often-repeated “78% success” claim is not the trial result |
| Santos et al., 2022 | 120 sexual and gender minority men with mild-to-moderate AUD; targeted 50 mg naltrexone or placebo for 12 weeks | Naltrexone reduced binge-drinking days and several secondary drinking outcomes | A specific population and short treatment period; not proof of the same effect for everyone |
Questions a clinician should resolve
Targeted dosing is a treatment decision, not a do-it-yourself drinking rule.
What is the actual goal?
Reduced heavy drinking, abstinence, craving, and treatment retention are different outcomes. Agree on measures and a review date.
Daily or targeted dosing?
The evidence and local product label may support different approaches. The plan should account for adherence and the likelihood of unplanned drinking.
What is the fallback plan?
Decide what happens after a missed dose, opioid pain emergency, worsening drinking, adverse effects, or no meaningful improvement.
Sources
- Heinälä et al., 2001 randomized trial (PubMed)
Daily treatment followed by a targeted phase; 121 participants.
- Santos et al., 2022 randomized trial (PubMed)
Targeted oral naltrexone in 120 sexual and gender minority men.
- US naltrexone tablet prescribing information (DailyMed)
Contraindications and opioid-overdose warnings.
Turn the method into specific questions
Ask whether daily or targeted dosing fits your goal, how unplanned drinking will be handled, what improvement will be measured, and what the safety plan is for pain or emergency care.
Content and sources reviewed